국내병원의 항암주사제 조제환경 및 약사 업무 현황 조사
Survey of Work Environment and Healthcare Workers Safety for Handling Antineoplastic Agents in Korean Hospitals
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : The American Society of Health-System Pharmacists has provided guidelines on handling hazardous drugs and updated its new and continuing concerns for health care workers. However, there are no such guidelines or regulations in Korea. This study aims to evaluate the work environment and the safety of healthcare workers during the preparation of antineoplastic agents in Korean hospitals. Methods : We invited a total of 110 hospitals with more than 500 beds to participate in our survey. Twenty nine hospitals participated. The self-completion questionnaire covered work place issues, the number of antineoplastic agent preparations, equipment and environmental quality control, and training about the handling of hazardous drugs. Results : There are three hospitals where the daily compounding number reached more than 600 and the average number per person was 36.5. The preparation room for hazardous drugs at nine hospitals remained positive or equal pressure. In addition, nine hospitals used a clean bench, which is not biologic safety cabinet. None of the 29 hospitals conducted an environmental sampling test to detect hazardous drugs and most of the hospitals performed an efficiency test of the biologic safety cabinet. All of the hospitals conducted personnel training and education about the safe handling of antineoplastic drugs but the length of the training period varied. In addition, none of the hospitals evaluate the health status of workers. Personal protective equipment included gowns, gloves, masks, hair caps and arm covers but not a respirator. The type of equipment and usage times varied. Most of hospitals complied with continuing preparation-compounding times of less than 2.5 hours. Conclusion : This was the baseline study to evaluate the work place and worker safety for the preparation of antineoplastic drugs. The result of our study demonstrates that it is necessary to establish standardized guidelines and improve working conditions for the handling of hazardous drugs in Korean hospitals.
Abstract
Purpose : The American Society of Health-System Pharmacists has provided guidelines on handling hazardous drugs and updated its new and continuing concerns for health care workers. However, there are no such guidelines or regulations in Korea. This study aims to evaluate the work environment and the safety of healthcare workers during the preparation of antineoplastic agents in Korean hospitals. Methods : We invited a total of 110 hospitals with more than 500 beds to participate in our survey. Twenty nine hospitals participated. The self-completion questionnaire covered work place issues, the number of antineoplastic agent preparations, equipment and environmental quality control, and training about the handling of hazardous drugs. Results : There are three hospitals where the daily compounding number reached more than 600 and the average number per person was 36.5. The preparation room for hazardous drugs at nine hospitals remained positive or equal pressure. In addition, nine hospitals used a clean bench, which is not biologic safety cabinet. None of the 29 hospitals conducted an environmental sampling test to detect hazardous drugs and most of the hospitals performed an efficiency test of the biologic safety cabinet. All of the hospitals conducted personnel training and education about the safe handling of antineoplastic drugs but the length of the training period varied. In addition, none of the hospitals evaluate the health status of workers. Personal protective equipment included gowns, gloves, masks, hair caps and arm covers but not a respirator. The type of equipment and usage times varied. Most of hospitals complied with continuing preparation-compounding times of less than 2.5 hours. Conclusion : This was the baseline study to evaluate the work place and worker safety for the preparation of antineoplastic drugs. The result of our study demonstrates that it is necessary to establish standardized guidelines and improve working conditions for the handling of hazardous drugs in Korean hospitals.
참고문헌 (17)
- American Society of Hospital Pharmacists, "ASHP guidelines on handling hazardous drugs", Am J Health-syst Pharm, 63(2), pp.1172~1193 (2006)
- 김정태, "병원 약제 부서에서의 중앙 집중식주사제조제를 위한 시설 및 장비 규정", 병원약사회지, 19(2), pp.202~207 (2002)
- American Society of Hospital Pharmacists, "ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs", Am J Health-syst Pharm, 47, pp.1033~1049 (1990)
- Controlling occupational exposure to hazardous drugs, "Chapter 21. In: OSHA technical manual (OSHA Instruction CPL 2-2.20B CH-4)", Directorate of Technical Support, Occupational Safety and Health Administration, ~ (1995)
- Baker E.S., "Monitoring occupational exposure to cancer chemotherapy drugs", Am J Health-Syst Pharm, 53, pp.2713~2723 (1996)
- Sessink P.J., "Drugs hazardous to healthcare workers: evaluation of methods for monitoring occupational exposure to cytostatic drugs", Drug. Saf, 20, pp.347~359 (1999)
- 한국산업안전보건공단, "의료기관 근로자의 화학물질 노출에 대한 보건관리지침", 3~12 (2006)
- 한국보건산업진흥원, "의료기관평가 지침서", 398~400 (2007)
- Connor T.H., "Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States", Am. J. Health Syst. Pharm, 56, pp.1427~1432 (1999)
- Dranitsaris G., "Are health care providers who work with cancer drugs at an increased risk for toxic events? A systemic review and metaanalysis of the literature", J Oncol Pharm Pract, 11, pp.69~78 (2005)
- Yoshida J., "Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan", J Oncol Pharm Pract, 17(1), pp.29~38 (2011)
- 손기호, "무균조제 항암제 취급의 안전관리", 약 학 회 지, 55(2), pp.81~90 (2011), 대한약학회
- Turci R., "Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods", Journal of Chromatography B, 789, pp.169~209 (2003)
- Harrison B.R., "Quality-assurance testing of staff pharmacists handling cytotoxic agents", Am J Health-Syst Pharm, 53, pp.402~407 (1996)